The role of structured inpatient lipid protocols in optimizing non-statin lipid lowering therapy: a review and single-center experience

The role of structured inpatient lipid protocols in optimizing non-statin lipid lowering therapy: a review and single-center experience

Dyslipidemia is a leading contributor to atherosclerotic cardiovascular disease (ASCVD). There has been a significant improvement in the treatment of dyslipidemia in the past 10 years with the development of new pharmacotherapies. The intent of this review is help enhance clinicians understanding of...

Full description

Bibliographic Details
Main Authors: Chad Gier, Ian Gilchrist, Matthew Fordham, Luke Riordan, Ella Milchan, Nidhi Patel, Azad Mohedi, Sahana Choudhury, Tara Kits, Regina Cohen, Joseph Doughtery, John P. Reilly, Andreas Kalogeropoulos, Tahmid Rahman, On Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
hyperlipidemia
quality improvement
ASCVD
lipid lower medications
LDL—Cholesterol
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2024.1284562/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2024.1284562/full

Similar Items